Product Information
METHYLPHENIDATE ER 15 MG CAP is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $2.6482 per EA under NDC 42858007645. Its NADAC has been published 96 times since Apr 17, 2024.
Strength
15 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858007645
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205831On Market Since
4/1/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 15 MG CAP has been published 96 times since Apr 17, 2024, and over the history we have for it it has declined 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6482 per EA |
|---|---|
| All-time high | $4.5612 (May 15, 2024) |
| All-time low | $2.4861 (Jul 17, 2024) |
| 52-week high | $2.6482 |
| 52-week low | $2.6482 |
| Median price | $2.6482 |
| Average price | $2.7585 |
| Largest weekly change | -29.5% (May 22, 2024) |
| Weeks tracked | 96 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methylphenidate Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 15 MG CAP, manufactured by Rhodes Pharmaceuticals L.P., is $2.6482 per EA (NDC 42858007645), effective Feb 11, 2026.
How has the price of METHYLPHENIDATE ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 15 MG CAP has declined 41.9%. It has been tracked across 96 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 15 MG CAP?
Since Apr 17, 2024, the NADAC for METHYLPHENIDATE ER 15 MG CAP has ranged from a low of $2.4861 (Jul 17, 2024) to a high of $4.5612 (May 15, 2024), with a median of $2.6482 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 15 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of METHYLPHENIDATE ER 15 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures METHYLPHENIDATE ER 15 MG CAP?
METHYLPHENIDATE ER 15 MG CAP (NDC 42858007645) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.
Related Drugs
Same classification